Carroll P - Search Results

1

A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.

McKiernan J, Donovan MJ, O'Neill V, Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A, Andriole G, Brown G, Wei JT, Thompson IM Jr, Carroll P. McKiernan J, et al. Among authors: carroll p. JAMA Oncol. 2016 Jul 1;2(7):882-9. doi: 10.1001/jamaoncol.2016.0097. JAMA Oncol. 2016. PMID: 27032035

2

Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer.

Diaz A, Roach M 3rd, Marquez C, Coleman L, Pickett B, Wolfe JS, Carroll P, Narayan P. Diaz A, et al. Among authors: carroll p. Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):323-9. doi: 10.1016/0360-3016(94)90011-6. Int J Radiat Oncol Biol Phys. 1994. PMID: 7523343

3

The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy.

Foster LS, Jajodia P, Fournier G Jr, Shinohara K, Carroll P, Narayan P. Foster LS, et al. Among authors: carroll p. J Urol. 1993 May;149(5):1024-8. doi: 10.1016/s0022-5347(17)36287-0. J Urol. 1993. PMID: 7683341

4

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate.

Roach M 3rd, Meehan S, Kroll S, Weil M, Ryu J, Small EJ, Margolis LW, Presti J, Carroll PC, Phillips TL. Roach M 3rd, et al. Among authors: carroll pc. J Urol. 1996 Nov;156(5):1719-23. J Urol. 1996. PMID: 8863578 Clinical Trial.

5

Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancer.

Roach M 3rd, Chen A, Song J, Diaz A, Presti J Jr, Carroll P. Roach M 3rd, et al. Among authors: carroll p. Semin Urol Oncol. 2000 May;18(2):108-14. Semin Urol Oncol. 2000. PMID: 10875450

6

Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer.

Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Carroll P, et al. Urology. 2001 Feb;57(2):217-24. doi: 10.1016/s0090-4295(00)00993-6. Urology. 2001. PMID: 11182324 No abstract available.

7

Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.

Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Carroll P, et al. Urology. 2001 Feb;57(2):225-9. doi: 10.1016/s0090-4295(00)00994-8. Urology. 2001. PMID: 11182325 Review. No abstract available.

8

Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE.

Ryan CJ, Elkin EP, Small EJ, Duchane J, Carroll P. Ryan CJ, et al. Among authors: carroll p. Urol Oncol. 2006 Sep-Oct;24(5):396-402. doi: 10.1016/j.urolonc.2005.09.003. Urol Oncol. 2006. PMID: 16962488

9

Overdiagnosis and overtreatment of prostate cancer.

Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R. Loeb S, et al. Among authors: carroll p. Eur Urol. 2014 Jun;65(6):1046-55. doi: 10.1016/j.eururo.2013.12.062. Epub 2014 Jan 9. Eur Urol. 2014. PMID: 24439788 Free PMC article. Review.

10

Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop.

Jarow JP, Thompson IM, Kluetz PG, Baxley J, Sridhara R, Scardino P, Carroll P, Albertsen P, Carter HB, Brawley O, Sartor O, Sandler H, Kiefert JJ, Morton RA Jr. Jarow JP, et al. Among authors: carroll p. Urology. 2014 May;83(5):975-8. doi: 10.1016/j.urology.2013.10.087. Epub 2014 Mar 22. Urology. 2014. PMID: 24661332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,088 results

Search Page

Filters